Bayer sued by shareholders over Monsanto acquisition

摘要

German law ?rms representing Bayer shareholders are suing the company for what it claims was a failure to warn shareholders adequately of the risks from pending lawsuits against Bayer’s acquisition target Monsanto. The share price of the Bayer group including the Crop Science and pharma divisions has almost halved since the takeover of Monsanto in June 2018 in the wake of lost lawsuits and mounting litigation against Monsanto for alleged health risks from the legacy business’s herbicide, Roundup (glyphosate). Bayer rejects the lawsuits as “unfounded”.